Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates

Jennifer R Timoshanko1, A Richard Kitching, Timothy J Semple

  • 1Centre for Inflammatory Diseases, Monash University, Department of Medicine, Monash Medical Center, Clayton, 3168 Victoria, Australia. jennifer.timoshanko@med.monash.edu.au

Insights

Granulocyte-macrophage colony-stimulating factor (GM-CSF) from kidney cells, not immune cells, is key for crescent formation in glomerulonephritis. Both sources are needed for full injury development.

Area of Science:

  • Nephrology
  • Immunology
  • Cell Biology

Background:

  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) plays a role in crescentic glomerulonephritis (GN).
  • Both kidney cells and inflammatory cells produce GM-CSF, but their distinct roles in renal injury are unclear.

Purpose of the Study:

  • To investigate the separate contributions of renal parenchymal and inflammatory cells to GM-CSF-driven renal injury in crescentic GN.
  • To determine the specific roles of leukocyte-derived versus renal cell-derived GM-CSF in the pathogenesis of GN.

Main Methods:

  • Creation of two GM-CSF chimeric mouse models: GM-CSF-/- --> Wild-Type (WT) and WT --> GM-CSF-/-.
  • Induction of crescentic anti-glomerular basement membrane GN in WT, GM-CSF-/-, and chimeric mice.
  • Analysis of inflammatory markers, cellular infiltration, and kidney injury indicators.

Main Results:

  • WT mice developed severe crescentic GN; GM-CSF-/- mice were protected.
  • Renal cell-derived GM-CSF was crucial for crescent formation, glomerular MHC II, serum creatinine, and inflammatory mediators.
  • Leukocyte-derived GM-CSF had a minor role in these aspects.
  • Both renal and leukocyte GM-CSF were required for macrophage accumulation, proteinuria, and interstitial infiltrate.

Conclusions:

  • Renal cell-derived GM-CSF is the primary driver of key inflammatory and injury markers in crescentic GN.
  • Leukocyte-derived GM-CSF contributes to overall glomerular injury but is not essential for initial crescent formation.
  • Targeting renal cell GM-CSF may be a therapeutic strategy for GN.